Cetuximab-induced rash is associated with overall survival in patients with recurrent/metastatic squamous cell carcinoma of head and neck.

Sema Sezgin GoksuAli Murat TatlıÇağlayan GeredeliMustafa AtcıAli Ayberk BesenHüseyin MertsoyluMükremin UysalMustafa ÖzdoğanSabin Göktaş AydınAhmet BiliciMustafa KaraağaçMehmet ArtaçMuhammet Ali KaplanSenar EbinçHasan Şenol Coşkun

Published in: Cancer chemotherapy and pharmacology (2021)

Cetuximab-induced rash is associated with better ORR and longer PFS and OS in patients with recurrent/metastatic HNSCC treated with Cetuximab and platinum-based chemotherapy.

Keyphrases

squamous cell carcinoma
locally advanced
high glucose
small cell lung cancer
diabetic rats
metastatic colorectal cancer
drug induced
wild type
endothelial cells
lymph node metastasis
free survival